The numbers for the quarter
Unitree Robotics closed the quarter ended September 30 with revenue of 665 million yuan, equivalent to about 99.7 million dollars, up 69.93% year on year. That is what the South China Morning Post reports, citing the first results published by the company since its listing. Despite the revenue surge, net profit excluding non-recurring items fell 17.42% to 105 million yuan.
According to the source, these are the first accounts made public by the Hangzhou-based company since its stock market debut. The figure is contained in a filing with the Shanghai Stock Exchange, as reported by the newspaper. In the same documentation, Unitree reports net profit attributable to shareholders of 387 million yuan for the first nine months of the year, up 270.54%.
The gap between revenue and operating profit is the central point of the quarterly report: commercial growth does not, for now, translate into an equivalent increase in core profits, precisely because of the cost structure in which the company is investing.
R&D spending and the strategy on software "brains"
The factor weighing on the result is identified by the same source as spending on research and development, which rose 249.58% from a year earlier to 127.04 million yuan. The amount is equivalent to about 19% of quarterly revenue. According to the South China Morning Post, the investment is intended for software, that is, the "brains" of the robotic bodies in which the company claims an industry-leading position.
The comparison between the two figures — revenue at +69.93% and R&D at +249.58% — explains the decline in core profit: investment growth is much faster than revenue growth. However, in the available material the company did not disclose payback periods for these investments or forecasts for future margins.
It therefore remains to be seen whether the increase in R&D spending is a temporary acceleration linked to the period following the listing or an orientation intended to last, and to what extent it will affect profitability in the coming quarters.
What is confirmed and what is missing
The confirmed data relate exclusively to the figures in the filing: quarterly revenue, profit excluding non-recurring items, R&D spending and net profit for the first nine months. However, the material provided does not include information on sales volumes, the geographic composition of revenue, gross margins or management statements.
The comparison between the quarter's performance and that of the nine months should be read with caution: the net profit attributable to shareholders refers to a longer period and is not directly comparable with the core profit of the third quarter alone. The material also does not clarify whether the 17.42% decline in profit excluding non-recurring items refers to the quarter or to another period; the source places it in the context of the quarterly results, but the wording leaves room for ambiguity that a check of the full document could resolve.
